Medicine and Dentistry
Sodium Valproate
100%
Prostate Cancer
62%
Cancer Cell
37%
In Vitro
37%
Xenograft
37%
Tumor Progression
25%
Tumor Xenograft
25%
Cell Cycle Arrest
25%
Growth Inhibition
25%
Therapeutic Procedure
25%
Neoplasm
12%
Programmed Cell Death
12%
Tissue Microarray
12%
Cyclin D1
12%
Receptor Expression
12%
Androgen Receptor
12%
Antiangiogenic Activity
12%
Histone Deacetylase Inhibitor
12%
P21
12%
Tumor Vascularization
12%
Growth
12%
Marker
12%
Cells
12%
Motivation
12%
Differentiation
12%
Drinking
12%
Water
12%
Immunology and Microbiology
Xenograft
62%
Cancer Cell
37%
Growth
37%
Cell Cycle Arrest
25%
Growth Inhibition
25%
Experimental Animal
12%
Apoptosis
12%
Animal
12%
Tumor Volume
12%
Cyclin D1
12%
Antiangiogenic Activity
12%
Cells
12%
Experiment
12%
Differentiation
12%
Reduction (Chemistry)
12%
Tumor Vascularization
12%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
37%
Growth
37%
Androgen Receptor
25%
Cell Cycle Arrest
25%
Growth Inhibition
25%
Apoptosis
12%
Tissue Microarray
12%
Experimental Animal
12%
Cyclin D1
12%
Animal
12%
P21
12%
LNCaP
12%
Tumor Volume
12%
Histone Deacetylase
12%
Antiangiogenic Activity
12%
Reduction (Chemistry)
12%
Motivation
12%
Experiment
12%
Tumor Vascularization
12%
Pharmacology, Toxicology and Pharmaceutical Science
Sodium Valproate
100%
Prostate Cancer
62%
Tumor Growth
25%
Neoplasm
12%
Experimental Animal
12%
Histone Deacetylase Inhibitor
12%
Tumor Vascularization
12%
Androgen Receptor
12%
Cyclin D1
12%
Animal
12%
Water
12%
Agricultural and Biological Sciences
Acid Treatment
25%
Cell Cycle Checkpoint
25%
Apoptosis
12%
Pellets
12%
Histone Deacetylase
12%
Drinking Water
12%
LNCaP
12%
Simulation Mode
12%
Cells
12%
Animals
12%